190,000 Participants in Actos Study Reveal Alarming Trend

December 11, 2011

An ongoing study of nearly 200,000 Type 2 diabetes patients who rely on Actos (pioglitazone) for diabetes treatment has revealed disconcerting results. For patients continuing treatments beyond one year, nearly 40 percent demonstrate a notably higher risk in bladder cancer.

 

More recent findings from the study suggest that men who take Actos (pioglitazone) are measurably more susceptible than women to bladder cancer. While it’s true that superficial tumors may be “shaved off” using electrocautery, most cases of bladder cancer require painful, exhausting chemotherapy or radiation. In many cases, bladder cancer ultimately proves fatal.

 

The dangerous drug attorneys at Fears Nachawati have the experience and expertise to protect the legal rights and financial interests of Actos victims. Don’t stand by as your rights are violated! Find out how you and your loved ones can take action by contacting our dedicated legal representatives today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)